Metoprolol

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9351 publications

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.

Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Randomized Clinical Trial.

Journal: JAMA cardiology
Published: June 17, 2026

Fate of Trace Organic Contaminants in the Hyporheic Zone: A Laboratory-Scale Column Experiment.

Fate of Trace Organic Contaminants in the Hyporheic Zone: A Laboratory-Scale Column Experiment.

Journal: Environmental science & technology
Published: June 16, 2026

A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking.

A hERG Blocker Facilitates K + Channel Current by Agonizing Pore Opening while Blocking.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients - A Register Study in Finland before COVID-19 Vaccines.

Candesartan, Metoprolol and Rosuvastatin Associated to Lower 30-Days Mortality in Adult COVID-19 Patients - A Register Study in Finland before COVID-19 Vaccines.

Journal: Journal of primary care & community health
Published: May 22, 2026

Calcium Channel Blockade Versus Beta-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial.

Calcium Channel Blockade Versus Beta-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: May 15, 2026

The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive).

The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive).

Journal: European heart journal supplements : journal of the European Society of Cardiology
Published: May 08, 2026

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Glaucoma Risk Associated With Calcitonin Gene-Related Peptide Inhibitor Use in Migraine: A Multinational Cohort Study.

Journal: Neurology
Published: May 06, 2026

Parental Advocacy in the NICU: A Unique Case of Infant Hypoglycemia Highlighting the Role of the Family in Improving Outcomes.

Parental Advocacy in the NICU: A Unique Case of Infant Hypoglycemia Highlighting the Role of the Family in Improving Outcomes.

Journal: Neonatal network : NN
Published: April 30, 2026

Electroconvulsive Therapy in the Presence of Cerebral Cavernous Hemangioma: A Case Report With Controlled Hemodynamic Strategy.

Electroconvulsive Therapy in the Presence of Cerebral Cavernous Hemangioma: A Case Report With Controlled Hemodynamic Strategy.

Journal: The journal of ECT
Published: April 27, 2026

Golimumab-Associated Myocarditis with Progressive Eosinophilia after Route Switch in Rheumatoid Arthritis.

Golimumab-Associated Myocarditis with Progressive Eosinophilia after Route Switch in Rheumatoid Arthritis.

Journal: European journal of case reports in internal medicine
Published: April 21, 2026

Serum metabolic signatures of cognitive resilience in a longitudinal aging cohort.

Serum metabolic signatures of cognitive resilience in a longitudinal aging cohort.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

Etripamil nasal spray (Cardamyst) for paroxysmal supraventricular tachycardia.

Etripamil nasal spray (Cardamyst) for paroxysmal supraventricular tachycardia.

Journal: The Medical letter on drugs and therapeutics
Published: April 10, 2026
Showing 1-12 of 9,351

Last Updated: 06/30/2026